Skip to content

Banking somatic stem cells for screening applications.

Banking somatic stem cells for screening applications. - Banking somatic stem cells for screening applications.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43433
Enrollment
Unknown
Registered
2016-06-22
Start date
2016-05-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Onderzochte aandoening is afhankelijk van het screeningsonderzoek, stamcellen en wensen van de client. Depends on the screeningtest stem cells and wishes of the client.

Interventions

None listed

Sponsors

Stem Cells Technologies
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years or older and mentally competent

Exclusion criteria

Exclusion criteria: Clients infected with HIV, Hepatitis B, Hepatitis C and Syphilis.

Design outcomes

Primary

MeasureTime frame
The main study parameter will be drug concentration gradients and viability of cell cultures, but the endpoints depends on the drug and tissue the client wants to screen.

Secondary

MeasureTime frame
Depends on the drug and tissue the client wants to screen.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)